| For: | Zhao BC, Wang ZJ, Mao WZ, Ma HC, Han JG, Zhao B, Xu HM. CXCR4/SDF-1 axis is involved in lymph node metastasis of gastric carcinoma. World J Gastroenterol 2011; 17(19): 2389-2396 [PMID: 21633638 DOI: 10.3748/wjg.v17.i19.2389] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i19/2389.htm |
| Number | Citing Articles |
| 1 |
Dmitry Osinsky, Antonina Kovelskaya, Larissa Bubnovskaya, Irina Ganusevich, Lilya Gumenyuk, Sergej Merentsev, Sergej Osinsky, Lesya Mamontova. CXCR4 Expression in Gastric Cancer and Bone Marrow: Association with Hypoxia-Regulated Indices, Disseminated Tumor Cells, and Patients Survival. Journal of Cancer Research 2015; 2015 doi: 10.1155/2015/980214
|
| 2 |
Calin Stoicov, Hanchen Li, Jian Hua Liu, JeanMarie Houghton. Mesenchymal Stem Cells Utilize CXCR4–SDF-1 Signaling for Acute, but Not Chronic, Trafficking to Gastric Mucosal Inflammation. Digestive Diseases and Sciences 2013; 58(9) doi: 10.1007/s10620-013-2782-y
|
| 3 |
Xian-Zhe Dong, Zi-Run Zhao, Yuan Hu, Yu-Pan Lu, Ping Liu, Lan Zhang. LncRNA COL1A1-014 is involved in the progression of gastric cancer via regulating CXCL12-CXCR4 axis. Gastric Cancer 2020; 23(2) doi: 10.1007/s10120-019-01011-0
|
| 4 |
STEFAN LANGHAMMER. Rationale for the design of an oncology trial using a generic targeted therapy multi-drug regimen for NSCLC patients without treatment options (Review). Oncology Reports 2013; 30(4) doi: 10.3892/or.2013.2631
|
| 5 |
Qilin Li, Jing Wang, Xinyao Meng, Weimin Chen, Jiexiong Feng, Jing Mao. Identification of autophagy‐related gene and lncRNA signatures in the prognosis of HNSCC. Oral Diseases 2023; 29(1) doi: 10.1111/odi.13889
|
| 6 |
Albert Zlotnik, Amanda M. Burkhardt, Bernhard Homey. Homeostatic chemokine receptors and organ-specific metastasis. Nature Reviews Immunology 2011; 11(9) doi: 10.1038/nri3049
|
| 7 |
Haiping Jiang, Dingyi Yu, Penghui Yang, Rongfang Guo, Mei Kong, Yuan Gao, Xiongfei Yu, Xiaoyan Lu, Xiaohui Fan. Revealing the transcriptional heterogeneity of organ‐specific metastasis in human gastric cancer using single‐cell RNA Sequencing. Clinical and Translational Medicine 2022; 12(2) doi: 10.1002/ctm2.730
|
| 8 |
Weizheng Mao, Xinhong Zhu, Dongqi Tang, Yuanyuan Zhao, Baocheng Zhao, Guiliang Ma, Xuebin Zhang, Gang An, Yang Li. TNF-α Expression in the UCB-MSCs as Stable Source Inhibits Gastric Cancers Growth in Nude Mice. Cancer Investigation 2012; 30(6) doi: 10.3109/07357907.2012.675385
|
| 9 |
Maryam Motamedi, Farnaz Razmkhah, Leila Rezakhani, Sorayya Ghasemi. Altered Expression of CD44, SIRT1, CXCR4, miR-21, miR-34a, and miR-451 Genes in MKN-45 Cell Line After Docetaxel Treatment. Journal of Gastrointestinal Cancer 2020; 51(2) doi: 10.1007/s12029-019-00274-1
|
| 10 |
Hiroshi Miyazaki, Kazuaki Takabe, W Andrew Yeudall. Chemokines, chemokine receptors and the gastrointestinal system. World Journal of Gastroenterology 2013; 19(19): 2847-2863 doi: 10.3748/wjg.v19.i19.2847
|
| 11 |
Zhi-qiang ZHU, Zhong-liang NING, Feng SHAO, Bin HU, Wei LIANG. Expression of CXCR4 in gastric cancer and its relationship with patient prognosis. Academic Journal of Second Military Medical University 2012; 32(1) doi: 10.3724/SP.J.1008.2012.00043
|
| 12 |
Bahram Nikkhoo, Ali Jalili, Shohreh Fakhari, Farshad Sheikhesmaili, Fardin Fathi, Daem Rooshani, Mohammad Ali Hoseinpour Feizi, Mehrnoush Nikzaban. Nuclear Pattern of CXCR4 Expression Is Associated with a Better Overall Survival in Patients with Gastric Cancer. Journal of Oncology 2014; 2014 doi: 10.1155/2014/808012
|
| 13 |
Xin-Yu Tan, Shi Chang, Wei Liu, Hui-Huan Tang. Silencing of CXCR4 Inhibits Tumor Cell Proliferation and Neural Invasion in Human Hilar Cholangiocarcinoma. Gut and Liver 2014; 8(2) doi: 10.5009/gnl.2014.8.2.196
|
| 14 |
XIU-JIE SHENG, YING-QUN ZHOU, QING-YUAN SONG, DONG-MEI ZHOU, QI-CAI LIU. Loss of breast cancer metastasis suppressor 1 promotes ovarian cancer cell metastasis by increasing chemokine receptor 4 expression. Oncology Reports 2012; 27(4) doi: 10.3892/or.2011.1596
|
| 15 |
Ramy Gadalla, Hebatallah Hassan, Sherif Abdelaziz Ibrahim, Mahmoud Salah Abdullah, Ahmed Gaballah, Burkhard Greve, Somaya El-Deeb, Mohamed El-Shinawi, Mona Mostafa Mohamed. Tumor microenvironmental plasmacytoid dendritic cells contribute to breast cancer lymph node metastasis via CXCR4/SDF-1 axis. Breast Cancer Research and Treatment 2019; 174(3) doi: 10.1007/s10549-019-05129-8
|
| 16 |
Aunchalee Jaroenlapnopparat, Khushboo Bhatia, Sahin Coban. Inflammation and Gastric Cancer. Diseases 2022; 10(3) doi: 10.3390/diseases10030035
|
| 17 |
Sebastiano Cavallaro. CXCR4/CXCL12 in Non-Small-Cell Lung Cancer Metastasis to the Brain. International Journal of Molecular Sciences 2013; 14(1) doi: 10.3390/ijms14011713
|
| 18 |
Ali I. Saeed, Fares Qeadan, Akshay Sood, Dorothy J. VanderJagt, Shiraz I. Mishra, Deirdre A. Hill, Tobias Peikert, Mohan L. Sopori. A novel cytokine profile associated with cancer metastasis to mediastinal and hilar lymph nodes identified using fine needle aspiration biopsy – A pilot study. Cytokine 2017; 89 doi: 10.1016/j.cyto.2016.08.011
|
| 19 |
Marta Tkacz, Maciej Tarnowski, Agata Poniewierska-Baran, Karol Serwin, Anna Madej-Michniewicz, Anna Deskur, Bogusław Czerny, Teresa Starzyńska. Impact of Selected Serum Factors on Metastatic Potential of Gastric Cancer Cells. Diagnostics 2022; 12(3) doi: 10.3390/diagnostics12030700
|
| 20 |
Juanli Qiao, Zhaojun Liu, Chen Yang, Liankun Gu, Dajun Deng. SRF promotes gastric cancer metastasis through stromal fibroblasts in an SDF1-CXCR4-dependent manner. Oncotarget 2016; 7(29) doi: 10.18632/oncotarget.10024
|
| 21 |
Giovanni Luca Gravina, Andrea Mancini, Paola Muzi, Luca Ventura, Leda Biordi, Enrico Ricevuto, Simona Pompili, Claudia Mattei, Ernesto Di Cesare, Emmanuele A. Jannini, Claudio Festuccia. CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models. The Prostate 2015; 75(12) doi: 10.1002/pros.23007
|
| 22 |
Marta Łukaszewicz-Zając, Maciej Szmitkowski, Ala Litman-Zawadzka, Barbara Mroczko. Matrix Metalloproteinases and Their Tissue Inhibitors in Comparison to Other Inflammatory Proteins in Gastric Cancer (GC). Cancer Investigation 2016; 34(7) doi: 10.1080/07357907.2016.1197237
|
| 23 |
Yizhuo Zhang, Qing Guo, Haifeng Zhao, Dandan Zhao, Xiaoxiong Wu, Weipeng Zhao, Yafei Wang, Bing Xia, Wanming Da. Expression of CXCR4 is an independent prognostic factor for overall survival and progression-free survival in patients with myelodysplastic syndrome. Medical Oncology 2013; 30(1) doi: 10.1007/s12032-012-0341-6
|
| 24 |
Miguel Gosalbez, Marie C. Hupe, Soum D. Lokeshwar, Travis J. Yates, John Shields, Muthu K. Veerapen, Axel S. Merseburger, Charles J. Rosser, Mark S. Soloway, Vinata B. Lokeshwar. Differential Expression of SDF-1 Isoforms in Bladder Cancer. Journal of Urology 2014; 191(6) doi: 10.1016/j.juro.2013.11.053
|
| 25 |
Elisabetta Marcuzzi, Roberta Angioni, Barbara Molon, Bianca Calì. Chemokines and Chemokine Receptors: Orchestrating Tumor Metastasization. International Journal of Molecular Sciences 2018; 20(1) doi: 10.3390/ijms20010096
|
| 26 |
Quan-Jun Deng, Xiao-Feng Xu, Jing Ren. RETRACTED ARTICLE: Effects of SDF-1/CXCR4 on the Repair of Traumatic Brain Injury in Rats by Mediating Bone Marrow Derived Mesenchymal Stem Cells. Cellular and Molecular Neurobiology 2018; 38(2) doi: 10.1007/s10571-017-0490-4
|
| 27 |
Wei Liu, Yan Yang, Zhe Ma, Chuan-Shan Zhang, Yan-Fen Cui, Qin Zhang, Hai-Bo Yu, Na Zhang, Qi Xin. CXCR7/CXCL12 axis is involved in lymph node and liver metastasis of gastric carcinoma. World Journal of Gastroenterology 2017; 23(17): 3053-3065 doi: 10.3748/wjg.v23.i17.3053
|
| 28 |
Mingzhi Han, Shunzeng Lv, Ya Zhang, Ruiyang Yi, Bin Huang, Hanhui Fu, Ruixiang Bian, Xingang Li. The prognosis and clinicopathology of CXCR4 in gastric cancer patients: a meta-analysis. Tumor Biology 2014; 35(5) doi: 10.1007/s13277-013-1603-4
|
| 29 |
Ping Yang, Yae Hu, Quansheng Zhou. The CXCL12-CXCR4 Signaling Axis Plays a Key Role in Cancer Metastasis and is a Potential Target for Developing Novel Therapeutics against Metastatic Cancer. Current Medicinal Chemistry 2020; 27(33) doi: 10.2174/0929867326666191113113110
|
| 30 |
Łukasz Kruszyna, Dawid Murawa, Paweł Piotr Jagodziński, Grzegorz Oszkinis, Zbigniew Krasiński. The Expression and Prognostic Significance of VEGF and CXCR4 in Gastric Cancer: Correlation with Angiogenesis, Lymphangiogenesis and Progression. Current Issues in Molecular Biology 2022; 44(7) doi: 10.3390/cimb44070212
|
| 31 |
Matteo Santoni, Sergio Bracarda, Massimo Nabissi, Francesco Massari, Alessandro Conti, Emilio Bria, Giampaolo Tortora, Giorgio Santoni, Stefano Cascinu. CXC and CC Chemokines as Angiogenic Modulators in Nonhaematological Tumors. BioMed Research International 2014; 2014 doi: 10.1155/2014/768758
|
| 32 |
Purvaba J. Sarvaiya, Donna Guo, Ilya Ulasov, Patrik Gabikian, Maciej S. Lesniak. Chemokines in tumor progression and metastasis. Oncotarget 2013; 4(12) doi: 10.18632/oncotarget.1426
|
| 33 |
Muhammad Haji Mansor, Mathie Najberg, Aurélien Contini, Carmen Alvarez-Lorenzo, Emmanuel Garcion, Christine Jérôme, Frank Boury. Development of a non-toxic and non-denaturing formulation process for encapsulation of SDF-1α into PLGA/PEG-PLGA nanoparticles to achieve sustained release. European Journal of Pharmaceutics and Biopharmaceutics 2018; 125 doi: 10.1016/j.ejpb.2017.12.020
|
| 34 |
Sara K. Daniel, Y. David Seo, Venu G. Pillarisetty. The CXCL12-CXCR4/CXCR7 axis as a mechanism of immune resistance in gastrointestinal malignancies. Seminars in Cancer Biology 2020; 65 doi: 10.1016/j.semcancer.2019.12.007
|
| 35 |
Magali Lecavalier‐Barsoum, Naz Chaudary, Kathy Han, Marianne Koritzinsky, Richard Hill, Michael Milosevic. Targeting the CXCL12/CXCR4 pathway and myeloid cells to improve radiation treatment of locally advanced cervical cancer. International Journal of Cancer 2018; 143(5) doi: 10.1002/ijc.31297
|
| 36 |
Li‐Jun Xue, Xiao‐Bei Mao, Li‐Li Ren, Xiao‐Yuan Chu. Inhibition of CXCL12/CXCR4 axis as a potential targeted therapy of advanced gastric carcinoma. Cancer Medicine 2017; 6(6) doi: 10.1002/cam4.1085
|
| 37 |
Shan Jiang, Manyu Luo, Xue Bai, Ping Nie, Yuexin Zhu, Hangxi Cai, Bing Li, Ping Luo. Cellular crosstalk of glomerular endothelial cells and podocytes in diabetic kidney disease. Journal of Cell Communication and Signaling 2022; 16(3) doi: 10.1007/s12079-021-00664-w
|
| 38 |
Marc S. Penn. Are stem cells the teacher or the student?. Current Opinion in Organ Transplantation 2012; 17(6) doi: 10.1097/MOT.0b013e32835a5aad
|
| 39 |
Wojciech Błogowski, Ewa Zuba-Surma, Daria Sałata, Marta Budkowska, Barbara Dołęgowska, Teresa Starzyńska. Peripheral trafficking of bone-marrow-derived stem cells in patients with different types of gastric neoplasms. OncoImmunology 2016; 5(4) doi: 10.1080/2162402X.2015.1099798
|
| 40 |
Jun Xiao, Hao Lai, Sheng‐Hong Wei, Zai‐Sheng Ye, Fu‐Sheng Gong, Lu‐Chuan Chen. RETRACTED: lncRNA HOTAIR promotes gastric cancer proliferation and metastasis via targeting miR‐126 to active CXCR4 and RhoA signaling pathway. Cancer Medicine 2019; 8(15) doi: 10.1002/cam4.1302
|
| 41 |
Sugandha Saxena, Rakesh K. Singh. Chemokines orchestrate tumor cells and the microenvironment to achieve metastatic heterogeneity. Cancer and Metastasis Reviews 2021; 40(2) doi: 10.1007/s10555-021-09970-6
|
| 42 |
YOON SUK OH, HA YON KIM, IK-CHAN SONG, HWAN-JUNG YUN, DEOG-YEON JO, SAMYONG KIM, HYO JIN LEE. Hypoxia induces CXCR4 expression and biological activity in gastric cancer cells through activation of hypoxia-inducible factor-1α. Oncology Reports 2012; 28(6) doi: 10.3892/or.2012.2063
|
| 43 |
Xinhong Zhu, Dongming Su, Shiying Xuan, Guiliang Ma, Zhenbo Dai, Tongyun Liu, Dongqi Tang, Weizheng Mao, Chenfang Dong. Gene therapy of gastric cancer using LIGHT-secreting human umbilical cord blood-derived mesenchymal stem cells. Gastric Cancer 2013; 16(2) doi: 10.1007/s10120-012-0166-1
|
| 44 |
Zhiwen Xiao, Guopei Luo, Chen Liu, Chuntao Wu, Liang Liu, Zuqiang Liu, Quanxing Ni, Jiang Long, Xianjun Yu. Molecular Mechanism Underlying Lymphatic Metastasis in Pancreatic Cancer. BioMed Research International 2014; 2014 doi: 10.1155/2014/925845
|
| 45 |
Jiamin Zhou, Yi Xiang, Teizo Yoshimura, Keqiang Chen, Wanghua Gong, Jian Huang, Ye Zhou, Xiaohong Yao, Xiuwu Bian, Ji Ming Wang. The Role of Chemoattractant Receptors in Shaping the Tumor Microenvironment. BioMed Research International 2014; 2014 doi: 10.1155/2014/751392
|
| 46 |
Jun Zhou, Jiqiang Li, Jie Chen, Xi Lan, Yanling Ai, Peiyao Liu, Jing Peng, Xinyu Pan, Yuanhao Zhang, Hebin Zhang, Xueyi Li, Yueqiang Wen, Wei Jiang, Jinhao Zeng. Decoding inflammatory mediators in the Correa's cascade: From chronic gastritis to carcinogenesis and targeted therapies. International Immunopharmacology 2025; 162 doi: 10.1016/j.intimp.2025.115191
|
| 47 |
EMMANOUIL LIARMAKOPOULOS, GEORGE THEODOROPOULOS, ANNA VAIOPOULOU, SPYROS RIZOS, GERASIMOS ARAVANTINOS, GREGORY KOURAKLIS, NIKOLAOS NIKITEAS, MARIA GAZOULI. Effects of stromal cell-derived factor-1 and survivin gene polymorphisms on gastric cancer risk. Molecular Medicine Reports 2013; 7(3) doi: 10.3892/mmr.2012.1247
|
| 48 |
Simona L. Schlereth, Nasrin Refaian, Sandra Iden, Claus Cursiefen, Ludwig M. Heindl. Impact of the Prolymphangiogenic Crosstalk in the Tumor Microenvironment on Lymphatic Cancer Metastasis. BioMed Research International 2014; 2014 doi: 10.1155/2014/639058
|
| 49 |
Meiying Song, Xueteng Wang, Jie Liang, Luoyang Wang, Jinzhen Cai, Bei Zhang. The CXCL12–CXCR4/CXCR7 axis as a therapeutic target in liver cancer: Enhancing immune evasion and the future of combination therapies. International Journal of Cancer 2026; 158(12) doi: 10.1002/ijc.70395
|
| 50 |
Cosmin Andrei Cismaru, Sergiu Chira, George Adrian Calin, Romana Netea-Maier, Ioana Berindan-Neagoe. On the potential origin of the zygote-like cancer stem cell with a focus on fusion for cell rescue. Frontiers in Cell and Developmental Biology 2026; 14 doi: 10.3389/fcell.2026.1797239
|
| 51 |
Thomas Thomaidis, Annett Maderer, Salah-Eddin Al-Batran, Janis Kany, Claudia Pauligk, Kristina Steinmetz, Arno Schad, Ralf Hofheinz, Harald Schmalenberg, Nils Homann, Peter Robert Galle, Markus Moehler. VEGFR-3 and CXCR4 as predictive markers for treatment with fluorouracil, leucovorin plus either oxaliplatin or cisplatin in patients with advanced esophagogastric cancer: a comparative study of the Arbeitsgemeinschaft Internistische Onkologie (AIO). BMC Cancer 2014; 14(1) doi: 10.1186/1471-2407-14-476
|
| 52 |
Wenna Guo, Xijia Chen, Liucun Zhu, Qiang Wang. A six-mRNA signature model for the prognosis of head and neck squamous cell carcinoma. Oncotarget 2017; 8(55) doi: 10.18632/oncotarget.21786
|
| 53 |
Maher Abdul-Hay, Jasmine Zain. Peripheral T-cell lymphoma: pharmacotherapy overview. Clinical Investigation 2012; 2(4) doi: 10.4155/cli.12.24
|
| 54 |
LU-MIN WEI, SHAN CAO, WEI-DONG YU, YU-LAN LIU, JING-TONG WANG. Overexpression of CX3CR1 is associated with cellular metastasis, proliferation and survival in gastric cancer. Oncology Reports 2015; 33(2) doi: 10.3892/or.2014.3645
|
| 55 |
Jenny Paupert, Maureen Van De Velde, Frédéric Kridelka, Agnès Noël. Molecular Mechanisms of Angiogenesis. 2014; doi: 10.1007/978-2-8178-0466-8_13
|
| 56 |
Alireza Nazari, Hossein Khorramdelazad, Gholamhossein Hassanshahi. Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer. International Journal of Clinical Oncology 2017; 22(6) doi: 10.1007/s10147-017-1187-x
|
| 57 |
Chaoyu Pang, Yongzheng Li, Ming Shi, Zhiyao Fan, Xin Gao, Yufan Meng, Shujie Liu, Changhao Gao, Peng Su, Xiao Wang, Hanxiang Zhan. Expression and clinical value of CXCR4 in high grade gastroenteropancreatic neuroendocrine neoplasms. Frontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1281622
|